JAGUAR HEALTH INC (JAGX) Stock Analyst Ratings
NASDAQ:JAGX - Nasdaq - US47010C8055 - Common Stock
ChartMill assigns a Buy % Consensus number of 86% to JAGX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 6.12. This target is 632.23% above the current price.
JAGX was analyzed by 7 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about JAGX.
In the previous month the buy percentage consensus was at a similar level.
JAGX was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2021-07-07 | Cantor Fitzgerald | Initiate | Overweight |